Forte Biosciences, Inc. (FBRX)
76.99
0.00 (0.00%)
USD |
NASDAQ |
Nov 13, 16:00
Forte Biosciences Price : 76.99 for Nov. 13, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | 76.99 | 76.99 | 76.99 | 76.99 | 0.000 |
| Nov 12, 2026 | 76.99 | 76.99 | 76.99 | 76.99 | 0.000 |
| Nov 11, 2026 | 76.99 | 76.99 | 76.99 | 76.99 | 0.000 |
| Nov 10, 2026 | 76.99 | 76.99 | 76.99 | 76.99 | 0.000 |
| Nov 09, 2026 | 76.99 | 76.99 | 76.99 | 76.99 | 0.000 |
| Nov 06, 2026 | 76.99 | 76.99 | 76.99 | 76.99 | 0.000 |
| Nov 05, 2026 | 76.99 | 76.99 | 76.99 | 76.99 | 0.000 |
| Nov 04, 2026 | 76.99 | 76.99 | 76.99 | 76.99 | 0.000 |
| Nov 03, 2026 | 76.99 | 76.99 | 76.99 | 76.99 | 0.000 |
| Nov 02, 2026 | 76.99 | 76.99 | 76.99 | 76.99 | 0.000 |
| Oct 30, 2026 | 76.99 | 76.99 | 76.99 | 76.99 | 0.000 |
| Oct 29, 2026 | 76.99 | 76.99 | 76.99 | 76.99 | 0.000 |
| Oct 28, 2026 | 76.99 | 76.99 | 76.99 | 76.99 | 0.000 |
| Oct 27, 2026 | 76.99 | 76.99 | 76.99 | 76.99 | 0.000 |
| Oct 26, 2026 | 76.99 | 76.99 | 76.99 | 76.99 | 0.000 |
| Oct 23, 2026 | 76.99 | 76.99 | 76.99 | 76.99 | 0.000 |
| Oct 22, 2026 | 76.99 | 76.99 | 76.99 | 76.99 | 0.000 |
| Oct 21, 2026 | 76.99 | 76.99 | 76.99 | 76.99 | 0.000 |
| Oct 20, 2026 | 76.99 | 76.99 | 76.99 | 76.99 | 0.000 |
| Oct 19, 2026 | 76.99 | 76.99 | 76.99 | 76.99 | 0.000 |
| Oct 16, 2026 | 76.99 | 76.99 | 76.99 | 76.99 | 0.000 |
| Oct 15, 2026 | 76.99 | 76.99 | 76.99 | 76.99 | 0.000 |
| Oct 14, 2026 | 76.99 | 76.99 | 76.99 | 76.99 | 0.000 |
| Oct 13, 2026 | 76.99 | 76.99 | 76.99 | 76.99 | 0.000 |
| Oct 12, 2026 | 76.99 | 76.99 | 76.99 | 76.99 | 0.000 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 18.75 |
| Alnylam Pharmaceuticals, Inc. | 165.04 |
| Anika Therapeutics, Inc. | 13.40 |
| Savara, Inc. | 4.64 |
| Arrowhead Pharmaceuticals, Inc. | 47.78 |
Price Related Metrics
| Price to Book Value | 8.580 |
| Earnings Yield | -6.66% |
| Market Cap | 1.577B |